Тобрадекс капли глазные, суспензия

Land: Kirgisistan

Sprog: russisk

Kilde: Правительства Кыргызской Республики (Департамент лекарственного обеспечения и медицинской техники)

Aktiv bestanddel:

Тобрамицин+Дексаметазон

Tilgængelig fra:

Новартис Фарма АГ (Новартис Фарма АГ)

ATC-kode:

S01CA01

INN (International Name):

Tobramycin+Dexamethasone

Lægemiddelform:

капли глазные, суспензия

Enheder i pakken:

5 мл №1

Recept type:

по рецепту

Fremstillet af:

с.а. АЛКОН КУВРЕР н.в. (Бельгия)

Terapeutisk område:

Противовоспалительный,антибактериальный препарат

Produkt oversigt:

ПЖВЛС: нет

Autorisation dato:

2018-12-27

Produktets egenskaber

vTBEPXAATO
IIHCTPyKIIIIflIIoMEA}III}IHCKOMyIIPIIMEHEH}IIo
TIPEIIAPATA
TOEPAAEKC
(ToBRADEX)
Topronoe
Ha3BaHrre
To6paaexc
MexAyHapoAnoe
HerlareH'l'oBaHHoe
Ha3BaHIre
Her
Cocras:
1
ur
cycneH3llu
coAePxoIT
leitcmaytoWue
?eulecmea:
3tvlr
ro6pauuquu
u
1
tr'tr
AeKcaMera3oHa;
BcnOaoeameiunute
6eu,lecm6a:
6ensalrOutls
xJIopuA'
lunaTpLrfl'
sAeTaT'
TT.TApOKCLI3TI,IJIUeJI1IOJIO3a,
HaTppIf,
xJIOpu.U,,
HaTpIIfl
Cynrsar
6e3sOAHrtfi'
TI'IJIOKCaIIOJI'
KIaCJIOTa
..p"u,
ulutruHarpr.rfl
fr4Apot(cllA
(gJIr
peryIlIpoBaHLL
pH),
no4a
oqruleHHail'
JlenapcrneHlrafl
QoPua
f lagnue
KaTIJII,I,
cycrreH3l'Ifl
.
Onncauue
Cycueusur
or
6eloro
Ao
rto.ITI'I6eloro
uBera'
@apvraxorepa[eBTutlecnafl
rpy[na
flporunorocflaJll,ITeJlbuble
u
npoTllBol'Iu$erquonusre
npe[apaTbl
B
rorra6uHa[uu'
fruoxoropu,IKocrepollAbl
I{
nporl'Inoun$erqnoHgble
[peflapaTLl
B
KoM6lIHaIIru'
Koa
ATX:
S01C
A01.
@apuaroloruqecKne
cnofi
crna
@apnaxoduH&MuKa.
Mexauusu
deilcmsun.
Mectsrre
Kopr[Kocrepor{Abr
oKtt3brBaror
nporI,IBoBocrIanI'ITeJIbHoe
AeficrBLre
14
I{cloJIE3yIorc'I
AJrfl
fleqeHllfl
BHerrrHero
BocIIaJreHlu
ula3
c
1950-x
roAoB.
fIoAasLf,IorCS
IIpO',BneHI'Ifl
BOC[aJIr,rTeJrbHoro
11poqecca,
TaKlre
KaK
oTeK,
oTiIoxeHI'Ie
(!ra6puua,
KaII]rJInflpHas
lvflaraws,
Mr,rrpallltfl
lefiroquton,
nponu$epaql'Ifl
KaIII{nJIrpoB,
OcaxAeHI'Ie
KOJInaIeHa'
O6paSOeauue
py6rlo,
u
$ra6po6lacTuqecKafl
nponra$epaUus.
Mectrrble
KopTuKocTepouAbl
s(btferrnnubl
IIpE
OCTp6IX
BOCITaJIUT9JI6H6D(
COCTOflHI,ISX
KOHbIOHKTI'IBbI'
CKJIepbI,
pOIOBI'IIIbI,
BeK,
paAyXKI'I
H
rrepeAnerg
CerMeHTa
p;IilIHOTO
a6.ngxa,
a
TaKxe
IIpfi
aJlnepruqecKlax
cocToflH]1f,x
IJIT13'
,{ercaueraroH
sBr.f,erc.,r
oAHraM
r,rs
Har.r6oree
MoIUHbrx
KoprI'IKocrepoI'IAoB;
oIr
n
5-14
pas
oSQerrr,rnnee
rpeAHI{3oJIoHa
u
s
25-75
pas
eQQertI{BHee
KoprI'I3oHa
I'I
il'IApoKoprlBoHa'
IlipnocrcueHgoe
3uarrenr{e
B
orHoureH[I.,I
MecrHofi
Tepafluu
3aKllotlaercfl
B
ToM,
tITo
o6ecue'reH[s
lr
,4e6caMeTa3oH
6o11ee
qeM
B
2000
pas
6onee
pacTBopI'IM,
qeM
r[ApoKopru3oH
IIJII'I
upeAHI43oJIoH'
'Toqurtil
Mexa,lr3M
upoTI{BoBoclaIII4TeJIb;oro
leftctsus
AeKc.N{eTa3oHa
He